IMMUTEP LTD (IMMP)
Immutep to Present Positive Interim Phase I Data for IMP761, a First-in-Class LAG-3 Agonist Antibody, at EULAR 2026
Immutep to Present Positive Interim Phase I Data for IMP761, a First-in-Class LAG-3 Agonist Antibody, at EULAR 2026
Visa and Brale Explore Private Stablecoin Settlement for Institutional Payments
Mobix Labs to Acquire U.S.-Built Drone Manufacturer Vision Aerial, Expanding Into Global Drone and Aerial Intelligence Markets
IMUNON Announces Up to $10 Million Cash Financing
LCI Industries Announces Leadership Transitions
One NZ Sets New Telco Industry Benchmark with UiPath, Accelerating Enterprise Mobile Provisioning from Days to Minutes
PepsiCo Announces Timing and Availability of Second-Quarter 2026 Financial Results
Zhongchao Inc. Announces 1-for-31 Share Consolidation
Cimpress to Present at the 16th Annual East Coast Ideas Conference on June 11, 2026 in New York
New Listings Fall 1.3%, One of the Biggest Weekly Declines of 2026